Ubicom Holdings. Inc. · TSE:3937
Ubicom — FY2021 Earnings Presentation
28 slides from Ubicom's earnings presentation, May 12, 2022
Slide 1: Presentation Materials for FY2021 Results
FY2021 Consolidated Business Results Presentation Materials for FY2021 Results Ubicom Holdings, Inc. TSE Prime: 3937 May 12, 2022 Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the J
Slide 2: FY2021 Highlights
FY2021 Highlights The established high-profit model turned out to be effective, and despite the strategic investment and the investment in recruitment of new graduates, we secured an increase in sales and profit. Profit hit a record high. Net Sales 4,726 Million yen Ordinary Income 1,055 Million yen
Slide 3: FY2021 (P/L)
FY2021 (P/L) In order to meet the strong demand for development and solutions that started from the second half, we enhanced strategic investment in leading-edge human resources and recruitment of new graduates. Ordinary income achieved 120.3% year on year. FY2020 FY2021 Year-on- % to % to Year [uni
Slide 4: Topics for FY2021 (medical)
Topics for FY2021 (medical) Offered the cloud-type medical claims inspection service as an OEM on a full-scale basis ・Started offering “Mighty Checker Cloud,” the unique cloud-type medical claims inspection service as an OEM, for accelerating the medical and healthcare DX, including online medical s
Slide 5: Topics for FY2021 (global & group)
Topics for FY2021 (global & group) Fostered strategic partnerships with clients in the global business. ・We fostered partnerships for development with clients, who are market leaders in respective industries, in order to promote digital transformation business and globalization, actualize mutually s
Slide 6: FY2021 Group's Strategic Investments Overview
FY 2021 Group’s Strategic Investments Overview Strategic investment (larger than ordinary investment) ・From 1Q to 3Q, we invested about 155 million yen earlier than scheduled. No additional investment in 4Q. ・In the second half, we entered the phase of recoupment of the strategic investment, and sal
Slide 7: FY2021 Segment Overview: Global Business
FY2021 Segment Overview: Global Business Global Business FY2020 FY2021 Year-on- Year (unit: million yen) Amount % to sales Amount % to sales Net Sales 2,761 100.0% 3,241 100.0% 117.4% Operating Income 492 17.8% 495 15.3% 100.6% • Strategic investments made in 1H ahead of schedule have been successfu
Slide 8: Promote acquisition of potential pillar clients and expand opportunities per customer
Global Business: Efforts and Progress Toward Mid-term Vision Promote acquisition of potential pillar clients and expand opportunities per customer ■FY2021 Results: acquired 12 new potential pillar clients In addition to acquiring new customer (medical 4Q solution provider), we focused on expanding t
Slide 9: Global Business: Advancement of Business Model
Global Business: Advancement of Business Model Generate pillar clients and high profitability through flexible offshore/onsite development Definition of pillar clients: Constant clients that are market leaders in each field with sales scale of several 100 million yen Establishment of Offshore (our d
Slide 10: Global Business: Themes for Mid- to Long-Term
Global Business: Themes for Mid- to Long-Term Promote business strategies targeted at the global market ■ Visions for the Global Business ① Offshore x bilingual (Japanese and English) x DX human resources (545,000 engineers short in 2030*) ② Provision of attractive career opportunities for young per
Slide 11: Global Business: Measures for achieving the mid-term vision
Global Business: Measures for achieving the mid-term vision To accelerate the development of pillar clients and the high unit price business model through collaborative creation with alliance partners, M&A targets, and business partners inside and outside Japan Standard model Alliance, M&A, Business
Slide 12: Global Business: Change and outlook of sales composition by strategic field
Global Business: Change and outlook of sales composition by strategic field We aim to expand the AI-related business by developing cutting-edge personnel. Since the outbreak of the coronavirus pandemic, the PC area has expanded steeply, due to the demand caused by the reform of workstyles, etc.
Slide 13: FY2021 Segment Overview: Medical Business
FY2021 Segment Overview: Medical Business Medical Business FY2020 FY2021 Year-on- Year (unit: million yen) Amount % to sales Amount % to sales Net Sales 1,435 100.0% 1,484 100.0% 103.4% Operating Income 734 51.1% 846 57.0% 115.4% • In the FY2021, operating income achieved 115.4% YoY. The new product
Slide 14: Medical Business: Advancement of Business Model
Medical Business: Advancement of Business Model Expansion of highly profitable foundation with the subscription model Trend of Medical Business Performance Sales Composition Trend of Medical Business (unit: million yen) *recurring ratio: continuous sales ratio 1,484 1,435 57.0% 1,282 1,301 1,169 1,0
Slide 15: Medical Business: Results and Visions
Medical Business: Results and Visions After the business was affected by the voluntary restraint of visiting medical institutions in the previous term (FY2020), the number of new users recovered in this term (FY2021). （+1,023） （+638） 18,475 ■No. of users *1 16,814 17,452 No. of users as of the end o
Slide 16: Medical Business: Effects of Mainstay Solutions
Medical Business: Effects of Mainstay Solutions ■Effects of Mighty Checker (MC) for Medical Affairs *1 (1) Reduction of operation time (2) Cost reduction and profit improvement Conventional medical claims inspection Inspection (Visual) of medical claims after introducing MC Inspection cost 100% Redu
Slide 17: Medical Domain: Growth Potential of each Solution
Medical Domain: Growth Potential of each Solution To promote further improvement of average spending per customer and recurring revenue earning capability through up-selling, cross-selling, and direct sales New Medical Platform Insurance Knowledge Platform SonaM Mighty QUBE GP margin of Mighty Check
Slide 18: Target Market Size for Medical Platforms
Target Market Size for Medical Platforms We aim to become the No. 1 platform in the niche medical field by leveraging our position as the market leader in DX solutions focused on medical institutions. New (domestic and overseas) Insurance Strategic Medical companies Markets institutions Insurance Kn
Slide 19: Medical Platform Utilization Strategy (Medium/Long-term Vision)
Medical Platform Utilization Strategy (Medium/Long-term Vision) To create more new markets through strategies to enclose the user community (potential market size: 300 billion yen*) *surveyed by our company ・Conversion of sales staff to consultants New market ・Medical engineer training Creation ・Str
Slide 20: Promotion of M&A strategy based on the results of acquisition of subsidiaries
Promotion of M&A strategy based on the results of acquisition of subsidiaries We aim to actualize new M&A that would contribute to our platformer strategy, by utilizing the know-how of post-merger integration (PMI) for medical business. ■Successful cases of M&A: Variation in results of medical busin
Slide 21: Earnings forecast for FY2022
Earnings forecast for FY2022 Both operating and ordinary incomes are expected to hit a record high, like in the previous fiscal year. Thanks to the effects of strategic investment, sales are projected to grow 15.2% year on year. Ordinary income is forecast to rise 20.5% year on year, as we will inve
Slide 22: Priority measures in FY2022
Priority measures in FY2022 To implement measures for strengthening the base for the second growth phase, while monitoring the profit balance １．To enrich the expert resources towards the ”Go Global Strategy” ⇒ Increase of young experts who can lead the next-generation businesses. ２．To enhance recrui
Slide 23: Promotion of the Leverage Strategy (the 2nd Growth Phase)
Promotion of the Leverage Strategy (the 2nd Growth Phase) To maximize the synergy between the existing business and M&A, and promote the development of new recurring-revenue/SaaS model ・Medical field Themes of the ・Pillar clients: + 20 companies ・Global market ×M&A second growth phase ・Sustainabilit
Slide 24: ESG: Towards Sustainable Development of Business, Society & Customer
ESG: Towards Sustainable Development of Business, Society & Customer ■Global Business ・DX Support (Business process reforms for clients through advanced technology support such as AI/Analytics/Automation/Cloud) ・Improvement of Japan’s global competitiveness through globalization support for domestic
Slide 25: Regarding measures for returning profit to shareholders
Regarding measures for returning profit to shareholders We aim to maximize shareholder value by improving corporate value. ■Dividend for FY2021 As the number of orders received has recently expanded and a profitable, robust recurring-revenue model for Maximization earning profit has been established
Slide 26: Company Overview
Company Overview ■Company name: Ubicom Holdings, Inc. (TSE Prime: 3937) ■Strategic industry: Medical, Financial/Public, Automotive, Manufacturing/Robotics, etc. ■Our Business: Global Business Dedicated in solving IT resource shortage in Japan and promoting DX (Digital Transformation), through provid
Slide 27: Cautionary Note on Forward Looking Statements
Cautionary Note on Forward Looking Statements This material may contain forward looking statements and forecasts regarding the future outlook at the time of publication. They are subject to risks and uncertainties including, but not limited to, domestic and international economic conditions such
Slide 28: © Ubicom Holdings, Inc.
© Ubicom Holdings, Inc.